Utah Money Watch’s Post

Conyers has advised Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology and aesthetics company focused on women’s health and breast reconstruction, in connection with its private placement of common shares and pre-funded warrants to certain institutional accredited investors. Pursuant to the securities purchase agreement, Establishment Labs agreed to sell two million common shares or, in lieu of common shares, pre-funded warrants at a price of US$25 per share. The aggregate gross proceeds from the offering before deducting related expenses are expected to be approximately US$50 million. Counsel Nicholas Kuria of Conyers’ BVI office advised on the transaction, working alongside O’Melveny & Myers LLP, New York. Read more here: https://loom.ly/DB_mEvU

To know more, read the full article on #theenterprise https://lnkd.in/gj6ZbZtC #Merck #EyeBio #Acquisition #EyeHealth #Restoret #DrugDevelopment #DiabeticMacularEdema #globalbusiness #theenterprisenews #followformore #global #finance

"How can you rapidly scale a family owned medical business? How do you do it once institutional investors are part of the shareholder structure?How do you keep the patient's interest paramount while also meeting shareholder demands?How do you achieve this without the company losing its identity, familiarity,"coolness" and the DNA that the founders instilled in the company?" These are some of the tough questions that my doctor fellows ask me lately.....I've done it but I don't have easy answers. I promise to strive to answer in the near future though.... 🏋♀️ #scaleup #medicalbusiness #investors #businessdevelopment #privatequity

🚨 NEW WAIT, BUT WHY? ALERT 🚨 Join Keith Wright, MBA, CCRP in an insightful conversation with Joel White, Founder of Marketcap Consulting on the latest episode of "Wait, but Why". They deep-dive into the economics of clinical research, discussing: 💰 How sponsors and sites negotiate fair market value in their budgets. 💼 Examining the M&A landscape and its impact on sites. 📈 Reasons why sites take on trials, delving into the potential benefits of trial participation. Check it out now: https://lnkd.in/eMJkk8uU #ResearchRevolution #sites #budgeting #clinicaltrials #clinicalresearch

As we discussed in our overview of the private equity, or PE, physician practice model, the buyer in an acquisition is often a PE-sponsored management services organization that purchases the nonclinical aspects of the practice’s business. Read more at https://buff.ly/3J0d3xq.

In Episode 6 of "Docs Doing Deal$," Epstein Becker & Green, P.C. explains healthcare deal basics for physicians. Dive deeper into this topic at the free 7th Annual Physician Transactions Conference on February 15th in San Francisco. Details: bit.ly/ptcSF24

To become attractive funding or M&A targets, medtech companies must prioritize de-risking and aligning their commercial, regulatory, and IP strategies. Want to learn about "How IP Can Drive Funding & Exits?" Join us and Greenberg Traurig, LLP's David Dykeman next week at DeviceTalks Boston to find out about best practices and pitfalls to avoid when building strategic patent portfolios to close funding, stay competitive and secure a successful exit. Learn more and register at Boston.DeviceTalks.com #DTBoston2024 #medtech #medicaldevices #medicaldevice #IP #intellectualproperty #funding Tom Salemi Kayleen Brown Chris Newmarker Danielle Kirsh Jim Hammerand

🟢 PRAXIS EXITS CAPITAL & REGIONAL BIDDING WAR! 🟢 💼 Praxis has announced it will not make an offer for Capital & Regional, ending its involvement in the bidding war. 💼 🏬 Earlier, Vukile Property Fund also withdrew after failing to agree on terms with Growthpoint, the majority shareholder. 🏬 💥 NewRiver remains the only potential bidder, with a deadline to decide on making an offer. 💥 #PLACEMAKINGNEWS

Bringing some positivity on "Blue Monday" with some exciting industry insights! We have some fall out from #jpm 24; some acquisitions, a start up spin out in Ireland; an update on the UK Medical Device Regulations and an outlook on 2024. Links to all articles in the comments. #jpm2024 #medtech #medicaltechnology #insidemedtech #medtechnews

Roper Technologies Syntellis: Talking About This Latest Acquisition https://lnkd.in/gWKdYtcV Roper Technologies is a well-known technology company that has a history of acquiring businesses in specific markets. They focus on various sectors like software, medical devices, and energy systems. The company is acknowledged for integrating acquisitions successfully and strategic moves that align with its long-term goals. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . #blogest #bloglikeyourown #bloginusa #blogger #blogs #blog #caeerblog #businessbloggerger #bloggingtips #seoblog #guestposting #RoperTechnologies #Syntellis #AcquisitionNews #BusinessExpansion #FinancialInsights #TechIndustry #SyntellisAcquisition #CorporateGrowth